Bennett's Choice

Bennett's Choice is a Canadian personalized healthcare company specializing in pharmacogenetics (PGx). The company provides genetic testing services designed to help clinicians and patients identify the most effective medications and dosages based on an individual's unique genetic profile. Their primary focus areas include mental health, chronic pain, and cardiovascular conditions, aiming to reduce the "trial and error" approach to prescribing. In 2020, the company was acquired by Inagene Personalized Healthcare to expand its reach in the Canadian and international markets. The Bennett's Choice platform analyzes key genetic markers to predict drug metabolism and efficacy across hundreds of common medications, facilitating more personalized and safer treatment plans.